A detailed history of Tower Research Capital LLC (Trc) transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,628 shares of IGMS stock, worth $62,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,628
Previous 258 1306.2%
Holding current value
$62,619
Previous $2,000 1100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.51 - $11.47 $21,938 - $38,653
3,370 Added 1306.2%
3,628 $24,000
Q1 2024

May 15, 2024

SELL
$8.68 - $17.36 $11,145 - $22,290
-1,284 Reduced 83.27%
258 $2,000
Q4 2023

Feb 13, 2024

SELL
$3.94 - $8.79 $5,342 - $11,919
-1,356 Reduced 46.79%
1,542 $12,000
Q3 2023

Nov 14, 2023

BUY
$6.66 - $10.64 $2,544 - $4,064
382 Added 15.18%
2,898 $24,000
Q2 2023

Aug 14, 2023

SELL
$8.86 - $14.0 $31,949 - $50,484
-3,606 Reduced 58.9%
2,516 $23,000
Q1 2023

May 09, 2023

BUY
$13.74 - $25.76 $75,899 - $142,298
5,524 Added 923.75%
6,122 $84,000
Q4 2022

Feb 10, 2023

SELL
$15.45 - $26.02 $21,954 - $36,974
-1,421 Reduced 70.38%
598 $10,000
Q3 2022

Nov 10, 2022

SELL
$15.42 - $27.01 $43,684 - $76,519
-2,833 Reduced 58.39%
2,019 $46,000
Q2 2022

Aug 15, 2022

SELL
$13.27 - $25.5 $79,235 - $152,260
-5,971 Reduced 55.17%
4,852 $87,000
Q1 2022

May 12, 2022

BUY
$13.42 - $29.73 $117,237 - $259,721
8,736 Added 418.59%
10,823 $289,000
Q4 2021

Feb 14, 2022

BUY
$27.59 - $66.39 $35,894 - $86,373
1,301 Added 165.52%
2,087 $61,000
Q3 2021

Nov 15, 2021

SELL
$65.76 - $90.65 $4,340 - $5,982
-66 Reduced 7.75%
786 $52,000
Q2 2021

Aug 16, 2021

SELL
$57.98 - $96.6 $43,542 - $72,546
-751 Reduced 46.85%
852 $71,000
Q1 2021

May 17, 2021

BUY
$71.56 - $121.23 $46,657 - $79,041
652 Added 68.56%
1,603 $123,000
Q4 2020

Feb 16, 2021

SELL
$47.41 - $115.03 $14,365 - $34,854
-303 Reduced 24.16%
951 $84,000
Q3 2020

Nov 16, 2020

SELL
$43.0 - $84.01 $73,100 - $142,817
-1,700 Reduced 57.55%
1,254 $92,000
Q2 2020

Aug 13, 2020

BUY
$51.3 - $75.21 $141,177 - $206,977
2,752 Added 1362.38%
2,954 $216,000
Q1 2020

May 15, 2020

BUY
$31.51 - $73.75 $6,365 - $14,897
202 New
202 $11,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.